ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Orders More Changes In ESA Label,

August 8, 2008

High Cervical Cancer Rates Indicate Access Problems

August 26, 2005

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

PET Three Months After Therapy Provides Early Warning Of Need For Intervention

November 30, 2007

In Brief: Four More O.I. Awards Announced; Pediatric Clinical Trials RFP Canceled

September 6, 1985